AR063038A1 - Agentes policiclicos para el tratamiento de infecciones por virus sincitial respiratorio - Google Patents

Agentes policiclicos para el tratamiento de infecciones por virus sincitial respiratorio

Info

Publication number
AR063038A1
AR063038A1 ARP070104296A ARP070104296A AR063038A1 AR 063038 A1 AR063038 A1 AR 063038A1 AR P070104296 A ARP070104296 A AR P070104296A AR P070104296 A ARP070104296 A AR P070104296A AR 063038 A1 AR063038 A1 AR 063038A1
Authority
AR
Argentina
Prior art keywords
aryl
alkyl
alkynyl
alkenyl
cycloalkenyl
Prior art date
Application number
ARP070104296A
Other languages
English (en)
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of AR063038A1 publication Critical patent/AR063038A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un compuesto de la formula (1) o su sal caracterizado porque R1 es seleccionado de alquilo C1-12, alquenilo C2-12, alquinilo C2-12, cicloalquilo-(CH2)mC3-7, cicloalquenilo -(CH2)nC4-7, arilo -(CH2)n, arilo-(CH2)m, alquilo C1-12, arilo-(CH2)n alquenilo C2-12, arilo -(CH2)n alquinilo C2-12 y heterociclilo -(CH2)n; n es 0-6 y dichos grupos alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo y heterociclilo son sustituidos opcionalmente; R2 es seleccionado de H, O, -CH2R3, - C(=Y)R3, -C(=Y)OR3, -C(=Y)N(R4)R3,-C(=Y)CH2N(R4)R3, -C(=Y)CH2SR3 y -S(O)wR5, donde R3 es seleccionado de hidrogeno, alquilo C1-12, alquenilo C2-12, alquinilo C2-12, cicloalquilo -(CH2)mC3-7, cicloalquenilo -(CH2)mC4-7, arilo -(CH2)m alquilo C1-12, arilo-(CH2)m alquenilo C2-12, arilo-(CH2)m alquinilo C2-12, y heterociclilo -(CH2)m; y donde R2 es -CH2R3 o -C(=Y)R3, R3 también puede ser seleccionado de -S-R5 y -O-R5; m es 0-6 R4 es hidrogeno o alquilo C1-6; R5 es alquilo C1-6, alquenilo C2-6, alquinilo C2-6, cicloalquilo C3-7, cicloalquenilo C4-7, bencilo, arilo o heterociclilo; w es 0, 1 o 2, y los grupos alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo y heterociclilo son sustituidos opcionalmente; X e Y son seleccionados independientemente de O, S y NR6, en donde R6 es seleccionado independiente de hidrogeno, alquilo inferior, hidroxi y alcoxi inferior; A conjuntamente con los átomos a los cuales está unido, forma un anillo aromático sustituido opcionalmente; B-C conjuntamente con los átomos a los cuales está unido, forma un anillo heterocíclico sustituido opcionalmente que tiene entre 5 y 8 átomos del anillo; D representa un grupo de union bivalente de entre uno y tres átomos de longitud, y si cuando A conjuntamente con los átomos a los cuales está unido forma un anillo fenilo no sustituido, X es O, D es -CH2-, B-C representan -CH2CH2- y R1 es fenilo no sustituido, entonces R2 no es H.
ARP070104296A 2006-09-28 2007-09-27 Agentes policiclicos para el tratamiento de infecciones por virus sincitial respiratorio AR063038A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84807306P 2006-09-28 2006-09-28

Publications (1)

Publication Number Publication Date
AR063038A1 true AR063038A1 (es) 2008-12-23

Family

ID=39229629

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104296A AR063038A1 (es) 2006-09-28 2007-09-27 Agentes policiclicos para el tratamiento de infecciones por virus sincitial respiratorio

Country Status (22)

Country Link
US (2) US8598194B2 (es)
EP (1) EP2069353B1 (es)
JP (1) JP5340943B2 (es)
KR (1) KR101488826B1 (es)
CN (1) CN101583614B (es)
AR (1) AR063038A1 (es)
AT (1) ATE532787T1 (es)
AU (1) AU2007302611C1 (es)
BR (1) BRPI0717536A2 (es)
CA (1) CA2664376C (es)
DK (1) DK2069353T3 (es)
ES (1) ES2376915T3 (es)
HK (1) HK1131988A1 (es)
IL (1) IL197783A (es)
MX (1) MX2009003336A (es)
NO (1) NO20091521L (es)
NZ (1) NZ575805A (es)
PL (1) PL2069353T3 (es)
PT (1) PT2069353E (es)
TW (1) TWI423972B (es)
WO (1) WO2008037011A1 (es)
ZA (1) ZA200901983B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005061513A1 (en) 2003-12-24 2005-07-07 Biota Scientific Management Pty Ltd Polycyclic agents for the treatment of respiratory syncytial virus infections
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
TWI508968B (zh) * 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
JP5890522B2 (ja) * 2011-08-05 2016-03-22 ビオタ サイエンティフィック マネージメント ピーティーワイ リミテッド 呼吸器合胞体ウイルス感染症処置用化合物
CA2853581A1 (en) * 2011-11-04 2013-05-10 Syngenta Participations Ag Pesticidal compounds
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137586C (es) 1963-04-11
US3507863A (en) 1963-12-18 1970-04-21 Sandoz Ag Isoindolones and method for preparing same
NL126596C (es) 1964-02-11
CH480350A (de) 1965-09-21 1969-10-31 Geigy Ag J R Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
NL129866C (es) 1965-09-21
US3379733A (en) 1965-12-07 1968-04-23 Sandoz Ag N-(omega-aminoalkyl)isoindoles and method for preparing same
CH481124A (de) 1966-09-21 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
GB1229651A (es) 1967-03-14 1971-04-28
CH482697A (de) 1967-03-17 1969-12-15 Geigy Ag J R Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
US3935218A (en) 1968-09-05 1976-01-27 American Home Products Corporation Imidazolinyl phenyl carbonyl compounds acid addition salts and related compounds
US3885037A (en) 1968-09-05 1975-05-20 American Home Prod Method of producing anorexia using imidazolinyl phenyl carbonyl compounds, their acid addition salts and related compounds
US3657221A (en) 1969-02-19 1972-04-18 American Home Prod Process for preparing 9b-substituted-1 - sulfonyl - 1 2 3 9b - tetrahydro-5h-imidazo(2 1-a)isoindol-5-ones
GB1322339A (en) 1970-03-10 1973-07-04 American Home Prod Imidazoline derivatives
US3770766A (en) 1970-03-10 1973-11-06 American Home Prod 2-(2-amino-2,2-dialkylamino-3-hydroxy-3-phenyl-1h-benz(f)isoindole-1-ones
US3624101A (en) 1970-03-10 1971-11-30 American Home Prod 2,3-DIHYDRO-5-ARYL-5H-BENZ{8 f{9 IMIDAZO{8 2,1-a{9 ISOINDOL-5-OLS
US3966955A (en) 1974-08-07 1976-06-29 American Home Products Corporation Anti-ulcer therapy
US4056536A (en) 1976-06-29 1977-11-01 Merck & Co., Inc. Pyrrolo[2,1-b][3]benzazepines
US4701208A (en) 1983-08-02 1987-10-20 American Cyanamid Company Dihydroimidazopyrrolopyridine, quinoline, thieno- and furo[2,3-b]pyridine, dihydrothieno- and furo[2,3-b]-pyridine, thieno- and furo[3,2-b]pyridine and dihydrothieno- and furo[3,2-b]pyridine herbicides and method for preparation thereof
DE3520390A1 (de) 1984-07-07 1986-02-06 Bayer Ag, 5090 Leverkusen Imidazo-pyrrolo-pyridin-derivate
EP0183993A3 (de) 1984-11-16 1987-12-09 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 2H-Imidazo[1',2':1,2]pyrrolo[3,4-b]pyridine und deren Verwendung als Unkrautbekämpfungsmittel
DE3674028D1 (de) 1985-03-12 1990-10-18 Ciba Geigy Ag Heterocyclisch kondensierte pyridin-verbindungen als herbizide.
DE3534948A1 (de) 1985-10-01 1987-04-09 Bayer Ag Fungizide und wachstumsregulatorische mittel
US4717414A (en) 1986-08-08 1988-01-05 Ppg Industries, Inc. Herbicidally active imidazopyrrolo-pyridine (or benzene) derivatives
DE3634952A1 (de) 1986-10-14 1988-04-21 Bayer Ag Imidazo-pyrrolo-pyridin-derivate
EP0475908A1 (de) 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
DE4103177A1 (de) 1991-02-02 1992-08-06 Boehringer Mannheim Gmbh Thiazolo-(2,3-a)isoindol-derivate und diese enthaltende arzneimittel
WO1992015310A1 (de) 1991-02-28 1992-09-17 Boehringer Mannheim Gmbh Verwendung von tricyclischen isoindolinonen als antivirale arzneimittel, sowie neue optisch aktive isoindolinone
DE4108395A1 (de) 1991-03-15 1993-01-28 Boehringer Mannheim Gmbh Verwendung von oxazolo-(2,3-a)isoindol-und imidazo(2,1-a)-isoindol-derivaten als antivirale arzneimittel sowie neue oxazolo(2,3-a)isoindol-derivaten
DE4129779A1 (de) 1991-09-07 1993-03-11 Boehringer Mannheim Gmbh Neue tricyclische thiazol- und oxazol-derivate und diese enthaltende arzneimittel
JPH0780886B2 (ja) * 1992-05-15 1995-08-30 ナショナル・サイエンス・カウンシル 三環結合ヒドロキシグアニジン、その製造法及びそれを含む抗癌組成物
WO2001014386A1 (fr) 1999-08-25 2001-03-01 Banyu Pharmaceutical Co., Ltd. Nouveaux dérivés isoindole
AU751826B2 (en) * 2000-02-14 2002-08-29 Mobility Electronics, Inc. Linked Bridge
US6489338B2 (en) 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
JP4058663B2 (ja) * 2000-09-22 2008-03-12 有機合成薬品工業株式会社 リボース１−リン酸類及びヌクレオシド化合物の製造方法
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US20040161846A1 (en) 2000-11-22 2004-08-19 Mason Anthony John Method of expression and agents identified thereby
WO2002066479A1 (fr) 2001-02-23 2002-08-29 Banyu Pharmaceutical Co.,Ltd. Derives de l'isoindole
AUPR878401A0 (en) 2001-11-09 2001-12-06 Biota Holdings Ltd Methods for identifying or screening anti-viral agents
WO2005061513A1 (en) * 2003-12-24 2005-07-07 Biota Scientific Management Pty Ltd Polycyclic agents for the treatment of respiratory syncytial virus infections
ES2567197T3 (es) 2005-04-28 2016-04-20 Viiv Healthcare Company Derivado de carbamoilpiridona policíclico que tiene actividad inhibidora de la integrasa del VIH
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑

Also Published As

Publication number Publication date
MX2009003336A (es) 2009-05-28
US8598194B2 (en) 2013-12-03
ATE532787T1 (de) 2011-11-15
IL197783A (en) 2014-01-30
PL2069353T3 (pl) 2012-04-30
US9675694B2 (en) 2017-06-13
CA2664376C (en) 2015-06-02
TWI423972B (zh) 2014-01-21
HK1131988A1 (en) 2010-02-12
EP2069353B1 (en) 2011-11-09
CN101583614A (zh) 2009-11-18
JP2010504915A (ja) 2010-02-18
CN101583614B (zh) 2014-01-22
KR20090073212A (ko) 2009-07-02
BRPI0717536A2 (pt) 2013-10-22
DK2069353T3 (da) 2012-02-20
WO2008037011A1 (en) 2008-04-03
ZA200901983B (en) 2010-03-31
US20140004111A1 (en) 2014-01-02
AU2007302611A1 (en) 2008-04-03
EP2069353A4 (en) 2010-09-15
ES2376915T3 (es) 2012-03-20
TW200831505A (en) 2008-08-01
RU2009115872A (ru) 2010-11-10
AU2007302611B2 (en) 2013-06-20
IL197783A0 (en) 2009-12-24
NZ575805A (en) 2012-03-30
NO20091521L (no) 2009-04-21
CA2664376A1 (en) 2008-04-03
JP5340943B2 (ja) 2013-11-13
AU2007302611C1 (en) 2013-11-21
EP2069353A1 (en) 2009-06-17
KR101488826B1 (ko) 2015-02-03
PT2069353E (pt) 2012-02-06
US20100021458A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
AR063038A1 (es) Agentes policiclicos para el tratamiento de infecciones por virus sincitial respiratorio
AR063015A1 (es) Derivados de quinazolinona 5-sustituida y composiciones que los comprenden y metodos para utilizarlos en el tratamiento del cancer
AR090868A1 (es) Composiciones plaguicidas y procesos relacionados con ellas
PE20120058A1 (es) Derivados de imidazopirazina como inhibidores de syk
AR053120A1 (es) Aminopiridinas como inhibidores de beta secretasa
ECSP099461A (es) Compuesto heteromonocíclico y uso del mismo
CO6160315A2 (es) Agonistas de piridona del receptor acoplado a proteina g gpr119
AR056979A1 (es) Derivados de dihidrobenzofuranos y usos de los mismos
GT200600205A (es) Nuevos herbicidas
PE20130157A1 (es) Inhibidores de la polimerasa virica
CO5611131A2 (es) Derivados de 5-feniltiazol y su uso como inhibidores de pi3 cinasa
AR098912A1 (es) Inhibidores de syk
CO6341610A2 (es) Compuesto heterociclilo aromatico que contiene nitrogeno.
AR054621A1 (es) 1-aril-4-ciclopropilpirazoles sustituidos
AR060590A1 (es) Compuestos imidazo
CO6270288A2 (es) Composicion fungicida que comprende cantidades significativamente efectivas de un derivadio de amida de acido carboxilico o su sal
CO6251282A2 (es) Oxazolidinonas sustituidas y su uso
AR068115A1 (es) Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
PE20180121A1 (es) Imidazopirazinonas como inhibidores de pde1
AR061520A1 (es) Derivados de cinamoil-piperazina
AR070578A1 (es) Imidazolidinas fenil- sustituidas, medicamentos que comprenden dichos compuestos y su uso para producir medicamentos
AR098105A1 (es) Composiciones plaguicidas y métodos relacionados
PE20081700A1 (es) Derivados de acido de piranona sustituidos como agentes para tratar el sindrome metabolico
CO6270258A2 (es) Compuesto de quinolona el cual suprime la progresion de disfuncion neurologica al inhibir la progresion cronica de la enfermedad de parkinson o proteger las neuronas de dopamina de la etiologia de la enfermedad

Legal Events

Date Code Title Description
FB Suspension of granting procedure